D. Goldenberg

Radiolabeled antibodies as in-vivo cancer probes (review).

R. Sharkey, D. Goldenberg, 1993, International journal of oncology.

Pretargeted Radioimmunotherapy of Cancer

R. Sharkey, D. Goldenberg, 2010 .

Blocking NRG1 and Other Ligand-Mediated Her4 Signaling Enhances the Magnitude and Duration of the Chemotherapeutic Response of Non–Small Cell Lung Cancer

R. Carano, E. Jackson, G. Schaefer, 2013, Science Translational Medicine.

Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer

Mallika Singh, J. Eastham‐Anderson, R. Vij, 2015, Science Translational Medicine.

Identification of Somatic Structural Variants in Solid Tumors by Optical Genome Mapping

A. Pang, J. Broach, A. Hastie, 2021, medRxiv.

Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC)

W. El-Deiry, D. Dicker, P. Gokare, 2016, Clinical Cancer Research.

Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis

W. El-Deiry, D. Dicker, Charles D Smith, 2013, PloS one.